Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (81-90 of 431) with videos related to

Pageof 44
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2009
Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acidStergios A Polyzos, Athanasios D Anastasilakis, Evangelos Terpos
Hormones (Athens, Greece)|May 9, 2022
Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver diseaseStergios A Polyzos, Irene Lambrinoudaki, Dimitrios G Goulis
Journal of Gastroenterology and Hepatology|January 18, 2024
Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysisEvangelia S Makri, Kleo Evripidou, Stergios A Polyzos
Metabolism: Clinical and Experimental|December 4, 2018
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeuticsStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Metabolism: Clinical and Experimental|January 4, 2016
Adipokines in nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Metabolism: Clinical and Experimental|October 30, 2017
Juvenile Paget diseaseStergios A Polyzos, Tim Cundy, Christos S Mantzoros
Metabolism: Clinical and Experimental|December 3, 2014
Leptin in nonalcoholic fatty liver disease: a narrative reviewStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
European Journal of Endocrinology|April 26, 2018
THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras
European Journal of Internal Medicine|February 14, 2015
Circulating homocysteine in nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Michael A Tsoukas
Minerva Endocrinologica|October 7, 2016
Adipose tissue, obesity and non-alcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Pageof 44

Showing results (81-90 of 431) with videos related to

Sort By:
Pageof 44
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2009
Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acidStergios A Polyzos, Athanasios D Anastasilakis, Evangelos Terpos
Hormones (Athens, Greece)|May 9, 2022
Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver diseaseStergios A Polyzos, Irene Lambrinoudaki, Dimitrios G Goulis
Journal of Gastroenterology and Hepatology|January 18, 2024
Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysisEvangelia S Makri, Kleo Evripidou, Stergios A Polyzos
Metabolism: Clinical and Experimental|December 4, 2018
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeuticsStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Metabolism: Clinical and Experimental|January 4, 2016
Adipokines in nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Metabolism: Clinical and Experimental|October 30, 2017
Juvenile Paget diseaseStergios A Polyzos, Tim Cundy, Christos S Mantzoros
Metabolism: Clinical and Experimental|December 3, 2014
Leptin in nonalcoholic fatty liver disease: a narrative reviewStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
European Journal of Endocrinology|April 26, 2018
THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras
European Journal of Internal Medicine|February 14, 2015
Circulating homocysteine in nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Michael A Tsoukas
Minerva Endocrinologica|October 7, 2016
Adipose tissue, obesity and non-alcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Pageof 44